AllDocs -> cancers

THE PHASE 2 AND 3 GASTROINTESTINAL CANCER PIPELINE Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts, and the databases of H EM /O NC T ODAY . The publisher or editors do not assume responsibility for any errors or omissions. Compiled by Kristine Welsh, Associate Editor Generic Name Product Name Company Indication Phase Anti-gastrin therapeutic vaccine Not yet available Aphton Corporation Colorectal cancer ; pancreatic cancer ; stomach Phase 2/3 cancer ; esophageal cancer ; liver cancer Anti-idiotype antibody TriGem Titan Pharmaceuticals Colorectal cancer Phase 2 Anti-VEGF Not yet available Genetech Colorectal cancer Phase 3 Autologous vaccine OncoVAXCL ...

EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 33, No. 1, 8-14, March 2001 Detection of circulating tumor cells in patients with gastrointestinal tract cancer using RT-PCR and its clinical implications Yun Hee Noh 1 , Jung Ah Kim 2 , G-Rewo Lim 1 , Young Tae Ro 1 , Ja Hyun Koo 1 , Yong Sung Lee 2 , Dong Soo Han 3 , Hwon Kyum Park 4 and Myung Ju Ahn 3,5 1 Department of Biochemistry, College of Medicine, Konkuk University, Chungju 380-791, Korea 2 Department of Biochemistry, College of Medicine, Hanyang University, Seoul 133-791, Korea 3 Departments of Internal Medicine and 4 General Surgery, College of Medicine, Hanyang University Kuri Hospital, ...

PO Box 2345, Beijing 100023, China World J Gastroenterol 2006 February 7; 12(5):815-817 www.wjgnet.com World Journal of Gastroenterology ISSN 1007-9327 wjg@wjgnet.com © 2006 The WJG Press. All rights reserved. CASE REPORT Small gastrointestinal stromal tumor concomitant with early gastric cancer : A case report Ying-Lung Lin, Jeh-En Tzeng, Chang-Kou Wei, Chih-Wen Lin www.wjgnet.com Ying-Lung Lin, Jeh-En Tzeng, Chang-Kou Wei, Chih-Wen Lin, Department of Family Medicine, Pathology, General Surgery, Radiology, Buddhist Dalin Tzu Chi General Hospital, Chia Yi, Taiwan, China Correspondence to: Dr Jeh-En Tzeng, Department of Pathology, Buddhist Dalin Tzu Chi General Hospital, 2, Min Sheng Road, Dalin, Chia Yi, Taiwan, China. p121521@tzuchi.com.tw Telephone: +886-5-2648000-5725 Received: 2005-06-07 Accepted: 2005-08-03 Abstract ...

B.C. Cancer Agency Protocol Summary GIFUC Page 1 of 3 BCCA Protocol Summary for Palliative Chemotherapy for Upper Gastrointestinal Tract Cancer (Gastric, Esophageal, Gall Bladder Carcinoma and Cholangiocarcinoma) and Metastatic Anal Cancer using Infusional Fluorouracil and Cisplatin Protocol Code GIFUC Tumour Group Gastrointestinal Contact Physician GI Systemic Therapy ELIGIBILITY : Metastatic or unresectable adenocarcinoma of the upper gastrointestinal tract (stomach, esophagus, gall bladder, bile ducts) Metastatic squamous cell or cloacogenic carcinoma of the anal canal ECOG 0-2 EXCLUSIONS : CNS metastases Uncontrolled high blood pressure, unstable angina, symptomatic congestive heart failure, myocardial infarction within the preceding 6 months, serious uncontrolled cardiac dysrhythmia Inadequate hepatic ...

Dog AKC Number __ Please check all applicable boxes Cancer Hemangiosarcoma Affected Littermate Affected Produced affected offspring Lymphoma Affected Littermate Affected Produced affected offspring Mast cell Affected Littermate Affected Produced affected offspring Osteosarcoma Affected Littermate Affected Produced affected offspring Other _ Affected Littermate Affected Produced affected offspring Cardiac disorders Subaortic stenosis Affected Littermate Affected Produced affected offspring Dermatological disorders Atopic dermatitis Affected Littermate Affected Produced affected offspring Gastrointestinal disorders Bloat Affected Littermate Affected Produced affected offspring Megaesophagus Affected ...

cancer 1581 Wharton Department of Statistics Profiting from Data Mining Bob Stine Department of Statistics The Wharton School, Univ of Pennsylvania April 5, 2002 www-stat.wharton.upenn.edu/~bob Wharton Department of Statistics 2 Overview Critical stages of data mining process Choosing the right data, people, and problems Modeling Validation Automated modeling Feature creation and selection Exploiting expert knowledge, “insights” Applications Little detail – Biomedical: finding predictive risk factors More detail – Financial: predicting returns on the market Lots of detail – Credit: anticipating the onset of bankruptcy Wharton Department of Statistics 3 Predicting Health Risk Who is at risk for a disease? ...

FRIDAY Joint Symposium: MOGA / ANTIGER Neuroendocrine Tumours – Recent Advances in DIAGNOSIS AND Management 18 Neuroendocrine GEP-tumors: Advances in Diagnosis and Treatment By Kjell Öberg, M.D., Ph.D. Professor Endocrine Oncology Dept. of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden Neuroendocrine tumors of the gastrointestinal tract and pancreas constitute about 2 % of all malignant tumors. They include a number of different tumors, derived from cells of the diffuse neuroendocrine cell-system. The largest group of neuroendocrine tumors are the so called carcinoids with an incidence of about 2.5/100 000 per year. The old classification of neuroendocrine GEP-tumors is based on the embryonic origin, but there is a new WHO- classification taking into the consideration the tumor biology of different subtypes of neuroendocrine tumors. The tumors exhibit substantial differences in ...